NOVARTIS | A-1 ACID | NOVARTIS/ A-1 ACID |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 26.6 | 225.4 | 11.8% | View Chart |
P/BV | x | 3.3 | 8.2 | 40.0% | View Chart |
Dividend Yield | % | 4.6 | 0.4 | 1,059.6% |
NOVARTIS A-1 ACID |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
NOVARTIS Mar-23 |
A-1 ACID Mar-23 |
NOVARTIS/ A-1 ACID |
5-Yr Chart Click to enlarge
|
||
High | Rs | 763 | 390 | 195.8% | |
Low | Rs | 554 | 246 | 225.2% | |
Sales per share (Unadj.) | Rs | 153.4 | 287.5 | 53.4% | |
Earnings per share (Unadj.) | Rs | 41.9 | 3.2 | 1,310.7% | |
Cash flow per share (Unadj.) | Rs | 44.3 | 6.7 | 664.2% | |
Dividends per share (Unadj.) | Rs | 47.50 | 1.50 | 3,166.7% | |
Avg Dividend yield | % | 7.2 | 0.5 | 1,528.5% | |
Book value per share (Unadj.) | Rs | 314.2 | 42.1 | 746.4% | |
Shares outstanding (eoy) | m | 24.69 | 11.50 | 214.7% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 4.3 | 1.1 | 388.3% | |
Avg P/E ratio | x | 15.7 | 99.5 | 15.8% | |
P/CF ratio (eoy) | x | 14.9 | 47.6 | 31.2% | |
Price / Book Value ratio | x | 2.1 | 7.6 | 27.8% | |
Dividend payout | % | 113.5 | 47.0 | 241.6% | |
Avg Mkt Cap | Rs m | 16,262 | 3,656 | 444.8% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 356 | 13 | 2,795.3% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 3,787 | 3,306 | 114.6% | |
Other income | Rs m | 581 | 64 | 915.0% | |
Total revenues | Rs m | 4,369 | 3,369 | 129.6% | |
Gross profit | Rs m | 651 | 43 | 1,511.4% | |
Depreciation | Rs m | 61 | 40 | 151.5% | |
Interest | Rs m | 18 | 18 | 95.4% | |
Profit before tax | Rs m | 1,154 | 48 | 2,392.3% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 120 | 12 | 1,045.2% | |
Profit after tax | Rs m | 1,034 | 37 | 2,814.0% | |
Gross profit margin | % | 17.2 | 1.3 | 1,319.1% | |
Effective tax rate | % | 10.4 | 23.8 | 43.7% | |
Net profit margin | % | 27.3 | 1.1 | 2,456.4% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 7,861 | 458 | 1,716.7% | |
Current liabilities | Rs m | 2,683 | 143 | 1,874.9% | |
Net working cap to sales | % | 136.7 | 9.5 | 1,435.7% | |
Current ratio | x | 2.9 | 3.2 | 91.6% | |
Inventory Days | Days | 1,201 | 8 | 15,186.5% | |
Debtors Days | Days | 35 | 421 | 8.3% | |
Net fixed assets | Rs m | 12,656 | 236 | 5,363.4% | |
Share capital | Rs m | 123 | 115 | 107.3% | |
"Free" reserves | Rs m | 7,634 | 369 | 2,068.6% | |
Net worth | Rs m | 7,757 | 484 | 1,602.6% | |
Long term debt | Rs m | 0 | 47 | 0.0% | |
Total assets | Rs m | 20,517 | 694 | 2,956.9% | |
Interest coverage | x | 66.9 | 3.6 | 1,844.0% | |
Debt to equity ratio | x | 0 | 0.1 | 0.0% | |
Sales to assets ratio | x | 0.2 | 4.8 | 3.9% | |
Return on assets | % | 5.1 | 7.9 | 64.5% | |
Return on equity | % | 13.3 | 7.6 | 175.6% | |
Return on capital | % | 15.1 | 12.5 | 120.5% | |
Exports to sales | % | 2.1 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 80 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 80 | 0 | - | |
Fx outflow | Rs m | 946 | 0 | - | |
Net fx | Rs m | -866 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 448 | 187 | 239.1% | |
From Investments | Rs m | -1,533 | -35 | 4,350.0% | |
From Financial Activity | Rs m | -305 | -153 | 199.8% | |
Net Cashflow | Rs m | -1,389 | 0 | 385,916.7% |
Indian Promoters | % | 0.0 | 70.0 | - | |
Foreign collaborators | % | 70.7 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.7 | 2.9 | 24.4% | |
FIIs | % | 0.2 | 2.9 | 6.6% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 29.3 | 30.0 | 97.8% | |
Shareholders | 43,128 | 2,071 | 2,082.5% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare NOVARTIS With: ADANI ENTERPRISES REDINGTON MMTC SIRCA PAINTS INDIA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Novartis | A-1 ACID | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.22% | -0.15% | 1.18% |
1-Month | 7.46% | -2.29% | -0.75% |
1-Year | 81.59% | -0.85% | 61.82% |
3-Year CAGR | 23.12% | 60.26% | 18.16% |
5-Year CAGR | 8.47% | 45.35% | 19.79% |
* Compound Annual Growth Rate
Here are more details on the Novartis share price and the A-1 ACID share price.
Moving on to shareholding structures...
The promoters of Novartis hold a 70.7% stake in the company. In case of A-1 ACID the stake stands at 70.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Novartis and the shareholding pattern of A-1 ACID.
Finally, a word on dividends...
In the most recent financial year, Novartis paid a dividend of Rs 47.5 per share. This amounted to a Dividend Payout ratio of 113.5%.
A-1 ACID paid Rs 1.5, and its dividend payout ratio stood at 47.0%.
You may visit here to review the dividend history of Novartis, and the dividend history of A-1 ACID.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.